Indefinite Delivery Contract HHSN271201600006I

This Indefinite Delivery Contract is a parent IDIQ vehicle awarded by the National Institutes of Health's National Institute of Neurological Disorders and Stroke to Southern Research Institute, a non-profit research organization. The Pharmacology and Toxicology for Therapeutics Program (PTTP) IDIQ has a total potential value of $174,470,000 and a period of performance through September 12, 2026. Under this IDIQ, Southern Research has been awarded multiple task orders to provide drug discovery,...

This indefinite delivery contract (IDC) was awarded by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services, to Sri International, a non-profit research and development institute. The $9.75 million IDC has a period of performance from September 12, 2023 to September 11, 2028 and is for toxicological evaluations of potential medications to support NIDA's mission. Under this IDC, Sri International has been awarded two task orders so far....

The National Institutes of Health (NIH), through its National Institute on Drug Abuse (NIDA), has awarded a Basic Ordering Agreement (BOA) contract to Sri International, a nonprofit research and development institute. The purpose of this $9.75 million, single-award IDV contract is to conduct toxicological evaluations of potential medications to support NIDA's drug abuse research program. Under this IDV, NIDA has issued several cost-plus-fixed-fee task orders to Sri International, valued at...

This indefinite delivery contract was awarded by the National Cancer Institute, a component of the U.S. Department of Health and Human Services, to the non-profit research and development institute SRI International. The single-award contract, valued at a ceiling of $12,069,385, is for the analysis and synthesis of GMP and non-GMP bulk drugs and pharmaceutical formulations. With a period of performance running through April 2028, this contract enables the National Cancer Institute to efficiently...

This federal contract IDV award is for CRO (Contract Research Organization) support for medicinal chemistry lead optimization programs managed by the National Center for Advancing Translational Sciences (NCATS), which is part of the National Institutes of Health (NIH) within the Department of Health and Human Services. The prime contractor, SRI International, is a large non-profit research and development organization with a significant history of providing advanced scientific and technical...

This indefinite delivery contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to Sri International, a non-profit research institute. The $3.9 million contract supports NCATS' drug development programs by (1) developing and validating sensitive bioanalytical methods to quantify concentrations of novel biologics, (2) developing assays to measure anti-drug antibodies, and (3)...

The federal contract IDV award is for safety evaluation and toxicology studies and related services to support drug development efforts of the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH). The prime contractor, SRI International, a nonprofit research and development institute, will provide in vitro and in vivo exploratory and Investigational New Drug (IND)-directed toxicology studies for small molecule and biologic...

The federal contract IDV award is a $499,868 Other Transaction IDV awarded by the Defense Advanced Research Projects Agency (DARPA) to SRI International, a non-profit research and development institute. The contract, titled "EQUIP-A-PHARMA - PHASE 1", does not have a small business set-aside. SRI International, an established provider of scientific, engineering, and technical services to federal agencies, will deliver research and development in support of DARPA's mission. The contract...

This federal contract IDV was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the Department of Health and Human Services (HHS), to SRI International, a non-profit research and development institute. The IDV has a ceiling value of $20,011,859 and does not have any set-aside designations. It provides a vehicle for NICHD to efficiently procure a wide range of scientific, engineering, and technical services from SRI International,...

This indefinite delivery contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. federal government. The contract has a single awardee, Sri International, a non-profit research and development institute headquartered in Menlo Park, California. The contract has a ceiling value of $50,000,000 and a period of performance ending on September 14, 2032. The purpose of this contract is to provide INTERVENTIONAL AGENTS SAFETY AND...